Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US15118072Application Date: 2015-02-09
-
Publication No.: US10010547B2Publication Date: 2018-07-03
- Inventor: Robert George Boyle , David Winter Walker , Richard Justin Boyce , Scott Peterson , Francine Farouz , Cong Hung Vo
- Applicant: CASCADIAN THERAPEUTICS, INC.
- Applicant Address: US WA Seattle
- Assignee: Cascadian Therapeutics, Inc.
- Current Assignee: Cascadian Therapeutics, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: GB1402277.6 20140210
- International Application: PCT/US2015/015030 WO 20150209
- International Announcement: WO2015/120390 WO 20150813
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/497 ; A61K45/06 ; A61K31/4155 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D403/14 ; A61K31/454 ; A61K31/5377 ; A61K31/551 ; C07D401/10
Abstract:
This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.
Public/Granted literature
- US20160361310A1 PHARMACEUTICAL COMPOUNDS Public/Granted day:2016-12-15
Information query
